Live Breaking News & Updates on Zhongshan Hospital At Fudan University

Stay updated with breaking news from Zhongshan hospital at fudan university. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Tirzepatide Sheds Pounds in Chinese Adults With BMI as Low as 24

Tirzepatide Sheds Pounds in Chinese Adults With BMI as Low as 24
medpagetoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medpagetoday.com Daily Mail and Mail on Sunday newspapers.

New York , United States , Boston University , Frank Qian , Ttirzepatide Zepbound , Weiping Jia , Xiaoying Li , Zhongshan Hospital At Fudan University , Shanghai Jiao Tong University School Of Medicine , Zhongshan Hospital , Fudan University , East Asian , Public Health , Shanghai Jiao Tong University School , New York City ,

Zhongchao Inc. Promotes Standardized Liver Cancer Diagnosis and Treatment with Medical Associations and Experts

Share this article
Share this article
SHANGHAI, Jan. 13, 2021 /PRNewswire/ Zhongchao Inc. (NASDAQ: ZCMD) ( Zhongchao or the Company ), a healthcare services company offering patient management, online healthcare information, professional training and educational services, today announced that it co-sponsored the National Annual Conference for Standardized Liver Cancer Diagnosis and Treatment (the Annual Conference ) with China Association of Health Promotion and Education and Chinese Society of Liver Cancer.
In 2020, Zhongchao worked with medical associations and experts to jointly carry out a multi-year online education project on the diagnosis and treatment of primary liver cancer. This project aims to promote and implement the Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2019 Edition) (the Guidelines ) published by the National Health Commission of the People s Republic of China. Based on the professional interpretation and throug ....

Sherry Zheng , Weiguang Yang , Jia Fan , Pei Xu , Chinese Society Of Liver Cancer , Zhongshan Hospital At Fudan University , Zhongchao Inc , China Association Of Health Promotion , Weitian Group , Chinese Academy Of Sciences , Sunshine Health Forums , Prnewswire Zhongchao Inc , National Annual Conference , Standardized Liver Cancer Diagnosis , China Association , Health Promotion , Chinese Society , Primary Liver Cancer , National Health Commission , Annual Conference , Chinese Academy , Sciences Fellow , Zhongshan Hospital , Fudan University , General Supervisor , Chief Executive Officer ,

José M. Vega, M.D. Joins Moderna as Chief Safety Officer

José M. Vega, M.D. Joins Moderna as Chief Safety Officer
José M. Vega, M.D. Joins Moderna as Chief Safety Officer
Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Jos M. Vega, M.D. joined Moderna as Chief Safety Officer effective Monday, January 11, 2021. Dr. Vega will report to Chief Medical Officer Tal Zaks, M.D., Ph.D.
Jos brings a strategic level of leadership and deep experience in drug development and pharmacovigilance in global biopharmaceutical companies including Merck and Amgen, said Dr. Zaks. I am thrilled to welcome Jos to the Moderna team as we enter the next phase of growth of our company. ....

Sherry Zheng , Weiguang Yang , Jia Fan , Pei Xu , Chinese Society Of Liver Cancer , Zhongshan Hospital At Fudan University , Zhongchao Inc , China Association Of Health Promotion , Weitian Group , Chinese Academy Of Sciences , Sunshine Health Forums , National Annual Conference , Standardized Liver Cancer Diagnosis , China Association , Health Promotion , Chinese Society , Primary Liver Cancer , National Health Commission , Annual Conference , Chinese Academy , Sciences Fellow , Zhongshan Hospital , Fudan University , General Supervisor , Chief Executive Officer , Private Securities Litigation Reform Act ,